RNS Number : 3252U
Marechale Capital PLC
28 July 2015
28 July 2015
Marechale Capital plc
("Marechale" or the "Company")
Consolidated Financial Statements for the year ended 31 March 2015.
Marechale is pleased to announce its final results for the year ended 31 March 2014
Chairman's Statement
We are pleased to report that Marechale completed the year strongly and, on the back of improving economic sentiment and more confidence in the equity markets, the Company's Gross Profit - revenue less commissions paid to 3rd parties - has increased by 39% from 517,600 to 719,000. Furthermore, as a result of our strategy of making investments in our client companies, we recorded 'Other Gains' (net) of 93,400 (2014: 152,400), resulting in a Profit before tax of 150,000 (2014: 79,400).
One part of our long-term strategic plan is to put the Company in a position to pay dividends and the Directors have decided to seek shareholder approval for a capital reorganisation that will be necessary before dividends can be paid. Shareholder approval will be sought at the 2015 AGM which is scheduled for the 17th September. Subject to receiving Court approval, it is planned subsequently to pay a dividend. A further announcement in this respect will be made in due course.
Another part of the long-term strategic plan is to motivate the Directors and staff by awarding them options which vest one third each year, over a three-year period, all tied to an uplift in the share price. At last year's AGM approval was obtained to award up to 10% of the issued share capital, of which 8%, were granted. It is the Board's intention to seek shareholder approval at this year's AGM for options to be granted on a further 10% of the issued share capital.
Marechale's core work is corporate finance advisory and capital fund raising for growth companies in two primary sectors in which the team have a long term track record; Leisure and Retail, and Renewable Energy.
Marechale helps management teams to finance or refinance in two key areas of activity; Growth Capital private equity transactions for more established businesses, and Development Capital, fundraising for smaller growth companies, the latter typically being Enterprise Investment Scheme (EIS) qualifying. As part of its success fee, the Company secures warrants or equity on most of its projects, so Marechale's shareholders have the opportunity to share in the potentially significant upside of the equity value in these businesses.
Equity investments and warrants are valued at 'fair value', typically at a price that reflects their last funding round, and the underlying unrealised movement in fair value is reflected (respectively) through the Revaluation Reserve and the Profit and Loss Account in accordance with IFRS9. Equity investments have increased by 40% to 151,700 and Warrants have increased by 66% to 128,250.
As a result of the above, and the Profit before tax, our Net assets have increased by 30% to 850,000.
During the year, Marechale has acted for a number of new and existing growth company clients, and has successfully completed a series of transactions, which are all detailed on the Company's website at: www.marechalecapital.com.
The Company's most significant initiative in the renewables sector is the development of large scale solar energy sites in the UK, through Marechale's associated company, Northfield UK Solar Limited (Northfield). Established in 2013, Northfield is developing a portfolio of solar sites. Marechale's stake in Northfield, at around 26% of the enlarged equity, is the Company's largest investment to date. As previously reported we are still awaiting the outcome of a planning appeal on the first site, on which a decision is due in the Autumn of 2015. Northfield's second large scale site is now in planning and we expect to hear a decision later this Summer. Whilst it is difficult to attribute values until planning permissions and grid connections for sites have been secured, there is significant potential uplift value for Marechale's shareholders; the valuation on the balance sheet represents the last funding round, and the Company's investment is being carried at 140,000, based on the Equity Method of valuation and including a provision to reflect the uncertainties of the planning process for its solar schemes and specifically a potential loss on appeal of the project mentioned above in proportion to Marechale's beneficial ownership % in Northfield. The environment for developing large scale solar schemes continues to be challenging, and whilst we are hopeful that value will be realised in due course, there are still significant risks involved.
Marechale has a growing reputation as one of the leading UK Advisors to the Leisure and Retail sector and, whilst it continues to see strong deal flow in this and its other core areas, it is always on the lookout for strong management teams with enterprising businesses in most sectors to support with growth and development capital. We remain committed to working with the management teams of quality companies to secure funding or refinancing capital from the Company's extensive list of private and institutional investors.
There is an appetite amongst our investor relationships to invest in high quality investment opportunities. The Directors believe that backing the right growth companies, whilst not without its risks, represents an interesting private equity investment class for investors looking to diversify their portfolios.
Marechale Capital is quoted on the AIM Market of the London Stock Exchange and continues to look at a number of potentially interesting acquisitions, investment and merger opportunities, particularly in fund management, and remains open to such approaches. However, none has been progressed to date. The Company is also looking to recruit staff to support its Corporate Finance and Sales activities.
Mark Warde-Norbury
Chairman
27 July 2015
For further information please contact:
Marechale Capital Mark Warde-Norbury / Patrick Booth-Clibborn
Tel: +44 (0)20 7628 5582
Smith & Williamson Corporate Finance Azhic Basirov / David Jones
Tel: +44 (0)20 7131 4000
Consolidated Income Statement
Year ended 31 March 2015
Year ended
Year ended
31-Mar
31-Mar
Notes
2015
2014
()
()
Continuing operations
Revenue
965,322
752,818
Cost of sales
2
(246,307)
(235,234)
Gross profit
719,015
517,584
Administrative expenses
(662,220)
(590,611)
Operating profit/ (loss)
56,795
(73,027)
Investment revenues
974
1,734
Other gains
72,458
31,361
Exceptional gain on dilution of interest in associate
166,140
141,125
Net loss in respect of associate
(31,191)
(21,786)
Provision for project loss in associate
(115,000)
-
Profit before tax
150,176
79,407
Taxation
-
-
Profit for the year on continuing operations
150,176
79,407
Profit per share
3
(Pence)
(Pence)
Basic
- Continuing operations
0.26
0.14
- Diluted
0.25
0.14
Consolidated Statement of Comprehensive Income
Year ended
Year ended
31-Mar
31-Mar
2015
2014
()
()
Profit for the year
150,176
79,407
Other comprehensive income
Revaluation of investments
38,246
12,254
38,246
12,254
Total recognised comprehensive income
(all attributable to owners of the parent)
188,422
91,661
Consolidated Balance Sheet
Year ended 31 March 2015
Year ended
Year ended
31-Mar
31-Mar
2015
2014
()
()
Non current assets
Investment in associate
139,794
119,845
Current assets
Available for sale investments
151,659
108,417
Trading investments
128,254
77,125
Trade and other receivables
491,108
221,003
Cash and cash equivalents
295,064
275,268
1,066,085
681,813
Total assets
1,205,879
801,658
Current liabilities
Trade and other payables
(356,043)
(149,319)
Total current liabilities
(356,043)
(149,319)
Net assets
849,836
652,339
Equity
Capital and reserves attributable to equity shareholders
Share capital
2,474,308
2,474,308
Share premium account
1,247,379
1,247,379
Revaluation reserve
90,135
51,889
Reserve for own shares
(50,254)
(50,254)
Retained losses
(2,920,807)
(3,070,983)
Reserve for share based payments
9,075
-
849,836
652,339
Statement of Changes in Equity
Year ended 31 March 2015
Share capital
Share premium
Revaluation reserve
Reserve for own shares
Retained earnings
Consolidated
()
()
()
()
()
Balance at 31 March 2013
2,474,308
1,247,379
39,635
(50,254)
(3,150,390)
Issue of ordinary share capital
-
-
-
-
-
Release of reserve for lapsed options
-
-
-
-
-
Transactions with owners
-
-
-
-
-
Total comprehensive income
Profit for the financial year
-
-
-
-
79,407
Revaluation during the financial year
-
-
12,254
-
-
Total comprehensive income
-
-
12,254
-
79,407
Balance at 31 March 2014
2,474,308
1,247,379
51,889
(50,254)
(3,070,983)
Issue of ordinary share capital
-
-
-
-
-
Reserve for share based payments
-
-
-
-
9,075
Transactions with owners
0
0
-
-
9,075
Total comprehensive income
Profit for the financial year
-
-
-
-
150,176
Revaluation during the financial year
-
-
38,246
-
-
Total comprehensive income
-
-
38,246
-
150,176
Balance at 31 March 2015
2,474,308
1,247,379
90,135
(50,254)
(2,911,732)
Company
Balance at 31 March 2013
2,474,308
1,247,379
39,635
(50,254)
(3,150,390)
Issue of ordinary share capital
-
-
-
-
-
Release of reserve for lapsed options
-
-
-
-
-
Transactions with owners
-
-
-
-
-
Total comprehensive income
Loss for the financial year
-
-
-
-
(39,930)
Revaluation during the financial year
-
-
12,254
-
-
Total comprehensive income
-
-
12,254
-
(39,930)
Balance at 31st March 2014
2,474,308
1,247,379
51,889
(50,254)
(3,190,320)
Issue of ordinary share capital
-
-
-
-
-
Reserve for share based payments
-
-
-
-
9,075
Transactions with owners
-
-
-
-
9,075
Total comprehensive income
Profit for the financial year
-
-
-
-
130,227
Revaluation during the financial year
-
-
38,246
-
-
Total comprehensive income
-
-
38,246
-
130,227
Balance at 31 March 2015
2,474,308
1,247,379
90,135
(50,254)
(3,051,018)
Movements of the Revaluation reserve consist of:
2015
2014
Unrealised gains
38,246
12,254
38,246
12,254
Reserves for own shares consists of:
Reserve for employee share ownership plan ('ESOP')
(50,254)
(50,254)
(50,254)
(50,254)
The Reserve for ESOP comprises 232,603 shares in the Group held in an ESOP Trust. As at 31 March 2015 (2014: nil), all the shares had been unconditionally granted to the Group's Associates which had an aggregate market value of 3,489 (2014: 4,652).
Consolidated Cash Flow Statement
Year ended 31 March 2015
Year ended
Year ended
31-Mar
31-Mar
2015
2014
()
()
Net cash from operating activities
Continuing operations: Operating profit/ (loss)
56,795
(73,027)
Provision for share based payments
9,075
-
Operating cash flows before movements in working capital
65,870
(73,027)
Movement in working capital
(Increase) in receivables
(270,105)
(28,438)
Increase in payables
206,726
63,275
Tax paid
-
-
(63,379)
34,837
Operating cash flow
2,491
(38,190)
Investment activities
Interest receivable
974
1,734
Proceeds on disposal of trading investments
17,705
44,807
Proceeds on disposal of available for sale investments
3,626
5,205
Expenditure on available for sale investments
(5,000)
(506)
Cash flow from investing activities
17,305
51,240
Financing
Issue of share capital
-
-
Cash flow from financing activities
-
-
Net increase in cash and cash equivalents
19,796
13,050
Cash and cash equivalents at start of the financial year
275,268
262,218
Cash and cash equivalents at end of the financial year
295,064
275,268
Increase in cash and cash equivalents
19,796
13,050
Notes to the financial statements
Year ended 31 March 2015
1. Basis of preparation
These financial statements have been prepared in accordance with International Financial Reporting Standards ('IFRS') as adopted by the European Union and the International Financial Reporting Interpretations Committee ('IFRIC') interpretations in accordance with the Companies Act 2006. The financial statements have been prepared on the historical cost basis as modified by the valuation of certain financial instruments.
2. Business and geographical segments
The directors consider that there is only one activity undertaken by the Group, that of corporate finance advisory. All of this activity was undertaken in the United Kingdom.
2015
2014
()
()
Broking commissions and fees earned from corporate finance
965,322
752,818
3. Earnings per share
Earnings
Earnings
()
()
Based on a profit of
150,176
79,407
No. shares
No. shares
Weighted average number of Ordinary Shares in issue
57,681,151
57,681,151
for the purpose of basic earnings per share
Weighted average number of Ordinary Shares in issue
59,988,397
57,681,151
for the purpose of diluted earnings per share - see also Note 5
4. Other Matters
The financial information for the year ended 31 March 2015 set out in this announcement does not constitute statutory financial statement, as defined in section 434 of the Companies Act 2006, but is based on the statutory financial statements for the year then ended. Those financial statements, upon which the auditors have issued an unqualified opinion, will be delivered to the Registrar of Companies.
Copies of the Company's full audited Annual Report and Financial Statements for the year ended 31 March 2015 will be sent to shareholders in due course and will be available on the Company's website: www.marechalecapital.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR RPMTTMBJTBLA
